Eli Lilly and Novo Nordisk agreed to discount their GLP-1 medications from $1350 per month to around $245 to $350 per month.

Mounjaro menus’ are lifesavers for people like me - IN FOCUS: There’s a reason why millions of people in the UK are on weight ...

A White House deal with Eli Lilly & Co. and Novo Nordisk to lower the prices of their popular obesity medicines, Zepbound and ...

Just five months after Novo Nordisk launched Wegovy in India, the Danish company has partnered (PDF) with Emcure ...

IT’S hard not to notice the amount of male celebrities who have stepped out sporting a much slimmer frame and chiselled ...

The deal will help expand the availability and marketing of this weight-loss medicine, especially in areas where Novo Nordisk ...

Novo Nordisk partners with Emcure to promote Wegovy, following Eli Lilly's recent collaboration with Cipla for tirzepatide in ...

Middle-class Indians trying to lose weight are embracing drugs such as Mounjaro in a country that has been called the world’s diabetes capital.

A growing number of GLP-1 users are 'microdosing' - they say small amounts of the drug have helped reduce symptoms of various ...

The anti-obesity drug registered sales of ₹100 crore in October, unseating the previous best-selling antibiotic Augmentin, ...